Makriyannis A - Search Results

1

The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female mice.

Raghav JG, Kumar H, Ji L, Vemuri K, Makriyannis A, Suh J, Leonard MZ, Dang V, Ty C, Marandola S, Kane N, Witt AS, Shaqour S, Miczek KA. Raghav JG, et al. Among authors: makriyannis a. Psychopharmacology (Berl). 2024 Mar;241(3):427-443. doi: 10.1007/s00213-023-06500-w. Epub 2023 Nov 25. Psychopharmacology (Berl). 2024. PMID: 38001264

2

Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats.

Spyridakos D, Mastrodimou N, Vemuri K, Ho TC, Nikas SP, Makriyannis A, Thermos K. Spyridakos D, et al. Among authors: makriyannis a. Int J Mol Sci. 2022 Dec 23;24(1):240. doi: 10.3390/ijms24010240. Int J Mol Sci. 2022. PMID: 36613692 Free PMC article.

3

Structural basis for activation of CB1 by an endocannabinoid analog.

Krishna Kumar K, Robertson MJ, Thadhani E, Wang H, Suomivuori CM, Powers AS, Ji L, Nikas SP, Dror RO, Inoue A, Makriyannis A, Skiniotis G, Kobilka B. Krishna Kumar K, et al. Among authors: makriyannis a. Nat Commun. 2023 May 9;14(1):2672. doi: 10.1038/s41467-023-37864-4. Nat Commun. 2023. PMID: 37160876 Free PMC article.

4

Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats.

Eid BG, Neamatallah T, Binmahfouz LS, Bagher AM, Alamoudi AJ, Aldawsari HM, Hanafy A, Hasan A, El-Bassossy HM, Abdel-Naim AB, Vemuri K, Makriyannis A. Eid BG, et al. Among authors: makriyannis a. Biomol Biomed. 2023 Nov 3;23(6):1069-1078. doi: 10.17305/bb.2023.9173. Biomol Biomed. 2023. PMID: 37212036 Free PMC article.

5

Correction: Eid et al. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. Molecules 2021, 26, 866.

Eid BG, Neamatallah T, Hanafy A, El-Bassossy HM, Binmahfouz L, Aldawsari HM, Hasan A, Abd El-Aziz G, Vemuri K, Makriyannis A. Eid BG, et al. Among authors: makriyannis a. Molecules. 2024 Feb 19;29(4):902. doi: 10.3390/molecules29040902. Molecules. 2024. PMID: 38398671 Free PMC article.

6

AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects.

Soler-Cedeño O, Alton H, Bi GH, Linz E, Ji L, Makriyannis A, Xi ZX. Soler-Cedeño O, et al. Among authors: makriyannis a. Neuropsychopharmacology. 2024 Oct;49(11):1678-1688. doi: 10.1038/s41386-024-01861-y. Epub 2024 Apr 10. Neuropsychopharmacology. 2024. PMID: 38600154 Free PMC article.

7

Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.

Bassir Nia A, Gibson CL, Spriggs SA, Jankowski SE, DeFrancisco D, Swift A, Perkel C, Galynker I, Honrao C, Makriyannis A, Hurd YL. Bassir Nia A, et al. Among authors: makriyannis a. J Psychopharmacol. 2023 May;37(5):484-489. doi: 10.1177/02698811221148604. Epub 2023 Jan 12. J Psychopharmacol. 2023. PMID: 36633290

8

Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201.

AlKhelb D, Burke EL, Zvonok A, Iliopoulos-Tsoutsouvas C, Georgiadis MO, Jiang S, Ho TC, Nikas SP, Makriyannis A, Desai RI. AlKhelb D, et al. Among authors: makriyannis a. Eur J Pharmacol. 2023 Dec 5;960:176168. doi: 10.1016/j.ejphar.2023.176168. Epub 2023 Oct 29. Eur J Pharmacol. 2023. PMID: 38059442 Free PMC article.

9

Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina.

Papadogkonaki S, Spyridakos D, Lapokonstantaki E, Chaniotakis N, Makriyannis A, Malamas MS, Thermos K. Papadogkonaki S, et al. Among authors: makriyannis a. Int J Mol Sci. 2023 Oct 28;24(21):15689. doi: 10.3390/ijms242115689. Int J Mol Sci. 2023. PMID: 37958673 Free PMC article.

10

Cannabinoids Block Fat-induced Incretin Release via CB₁-dependent and CB₁-independent Pathways in Intestinal Epithelium.

Perez PA, Wiley MB, Makriyannis A, DiPatrizio NV. Perez PA, et al. Among authors: makriyannis a. Gastro Hep Adv. 2024 Jul 22;3(7):931-941. doi: 10.1016/j.gastha.2024.07.006. eCollection 2024. Gastro Hep Adv. 2024. PMID: 39318720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

519 results

Search Page

Filters